Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
CNS Drugs|January 4, 2020
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple SclerosisDamiano Paolicelli, Alessia Manni, Antonio Iaffaldano, et al.Brain and Behavior|December 16, 2020
A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature reviewMosè Parisi, Alessia Manni, Francesca Caputo, et al.Journal of Clinical Pharmacology|April 24, 2015
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing studyDamiano Paolicelli, Alessia Manni, Vita Direnzo, et al.Frontiers in Neurology|March 25, 2021
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric MethodLuca Bollo, Pietro Iaffaldano, Maddalena Ruggieri, et al.European Journal of Ophthalmology|July 8, 2022
Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot StudyValeria Albano, Rosanna Dammacco, Alessia Manni, et al.Brain and Behavior|October 28, 2017
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohortAlessia Manni, Vita Direnzo, Antonio Iaffaldano, et al.Frontiers in Immunology|July 2, 2019
Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated CohortAlessia Manni, Antonio Iaffaldano, Giuseppe Lucisano, et al.Journal of Clinical Pharmacology|November 27, 2015
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis PatientsDamiano Paolicelli, Vita Direnzo, Alessia Manni, et al.Brain Sciences|August 23, 2020
Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis TherapyMaddalena Ruggieri, Concetta Domenica Gargano, Anna Ferretta, et al.BMC Psychology|July 29, 2025
The protective role of cognitive reserve in moderating depressive symptomatology in patients with multiple sclerosisMadia M Biasi, Paolo Taurisano, Alessia Manni, et al.Pageof 3